LangChain and LangGraph have patched three high-severity and critical bugs.

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

The arrival of the Wegovy pill (semaglutide), the first oral GLP-1 drug approved to treat obesity, means freedom of choice: Adults who are looking to lose weight and have at least one weight-related ...

Cloudflare says dynamically loaded Workers are priced at $0.002 per unique Worker loaded per day, in addition to standard CPU and invocation charges ...

If you've been around the skincare block as many times as I have, peptides will be nothing new to you. Everyone from No7, to The Inkey List to Olay includes the ingredient in their serums and ...

The phrase “eye stroke” has recently appeared in news reports about a very rare side-effect of weight-loss injections. It’s not a formal medical diagnosis, but a shorthand used to describe a condition ...

Injectable peptides are licensed ‘for research use only’, but that doesn’t deter biohackers from selling them or gym goers from conducting their own experiments with unregulated vials ordered from the ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Peptides have become a buzzy wellness trend, promoted ...

People who reach a healthy weight and improve their metabolic health on GLP-1 medications are typically told they’ll need to maintain a weekly dose indefinitely to keep the weight off. But emerging ...

With 2026 now in full swing, many are turning their attention to GLP-1 weight-loss medications like Mounjaro, either having started treatment or seriously considering it. However, a prominent expert ...

Every conversation you have with an AI — every decision, every debugging session, every architecture debate — disappears when the session ends. Six months of work, gone. You start over every time.